إعلان
إعلان
JAZZ
Jazz Pharmaceuticals, Inc.
173.17
USDبرعاية
+3.17
+1.87%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
173.10
-0.07
-0.04%
تقارير أرباح JAZZ
النسبة الإيجابية المفاجئة
JAZZ تفوق 22 من 40 آخر التقديرات.
55%
التقرير التالي
بيانات التقرير القادم
٢٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.18B
/$6.53
التغير الضمني من Q3 25 (Revenue/ EPS)
+4.47%
/-19.68%
التغير الضمني من Q4 24 (Revenue/ EPS)
+8.11%
/-1.06%
Jazz Pharmaceuticals, Inc. earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, JAZZ reported earnings of 8.13 USD per share (EPS) for Q3 25, beating the estimate of 6.03 USD, resulting in a 34.65% surprise. Revenue reached 1.13 مليار, compared to an expected 1.13 مليار, with a -0.41% difference. The market reacted with a -2.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of 6.53 USD, with revenue projected to reach 1.18 مليار USD, implying an decrease of -19.68% EPS, and increase of 4.47% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Jazz Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Jazz Pharmaceuticals, Inc. reported EPS of $8.13, beating estimates by 34.65%, and revenue of $1.13B, -0.41% below expectations.
How did the market react to Jazz Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -2.31%, changed from $137.22 before the earnings release to $134.05 the day after.
When is Jazz Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ٢٣ فبراير ٢٠٢٦.
What are the forecasts for Jazz Pharmaceuticals, Inc.'s next earnings report?
Based on 18
analysts, Jazz Pharmaceuticals, Inc. is expected to report EPS of $6.53 and revenue of $1.18B for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان